Wiki-CORONA

Search Results for: Pulmonary

5304 interactions found:

Sort by: Relevance Number of Pathways Number of Drugs Number of Diseases
Symbols Name 1 Name 2
Pathways 1
Pathways 2
Drugs 1
Drugs 2
Diseases 1
Diseases 2
BMP6 and TDGF1 bone morphogenetic protein 6 teratocarcinoma-derived growth factor 1
  • Signaling by NODAL
  • Regulation of signaling by NODAL
  • POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation
BMP6 and BMPER bone morphogenetic protein 6 BMP binding endothelial regulator
BMP6 and CHRDL2 bone morphogenetic protein 6 chordin like 2
BMP6 and SMAD5 bone morphogenetic protein 6 SMAD family member 5
  • Signaling by BMP
BMP7 and BMPR2 bone morphogenetic protein 7 bone morphogenetic protein receptor type 2
  • Molecules associated with elastic fibres
  • Signaling by BMP
BMPR1A and BMPR2 bone morphogenetic protein receptor type 1A bone morphogenetic protein receptor type 2
  • Signaling by BMP
  • Signaling by BMP
  • Hereditary mixed polyposis syndrome
  • Juvenile polyposis syndrome
BMPR1A and USP15 bone morphogenetic protein receptor type 1A ubiquitin specific peptidase 15
  • Signaling by BMP
  • Downregulation of TGF-beta receptor signaling
  • UCH proteinases
  • Ub-specific processing proteases
  • Hereditary mixed polyposis syndrome
  • Juvenile polyposis syndrome
BMPR1B and BMPR2 bone morphogenetic protein receptor type 1B bone morphogenetic protein receptor type 2
  • Signaling by BMP
  • Signaling by BMP
  • Acromesomelic dysplasia with genital anomalies
  • Brachydactyly, including: type A; type B; type D; type E
BMPR1B and VEPH1 bone morphogenetic protein receptor type 1B ventricular zone expressed PH domain containing 1
  • Signaling by BMP
  • Acromesomelic dysplasia with genital anomalies
  • Brachydactyly, including: type A; type B; type D; type E
BMPR1B and SMAD6 bone morphogenetic protein receptor type 1B SMAD family member 6
  • Signaling by BMP
  • Signaling by BMP
  • RUNX2 regulates bone development
  • Acromesomelic dysplasia with genital anomalies
  • Brachydactyly, including: type A; type B; type D; type E
BMPR2 and CRYAB bone morphogenetic protein receptor type 2 crystallin alpha B
  • Signaling by BMP
  • HSF1-dependent transactivation
  • Distal muscular dystrophies, including: Welander distal myopathy (WDM); Tibial muscular dystrophy (TMD); Nonaka distal myopathy with rimmed vacuoles (DMRV); Miyoshi myopathy (MM); Laing myopathy (MPD1); Distal nebulin myopathy (DNM); Distal desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Distal myotilinopathy (MFM3); Distal zaspopathy (MFM4); Distal myopathy 3 (MPD2, VCPDM)
  • Myofibrillar myopathies (MFM), including: Desminopathy (MFM1); alpha-B Crystallinopathy (MFM2); Myotilinopathy (MFM3); Zaspopathy (MFM4); Filaminopathy (MFM5); Bag3opathy
BMPR2 and TGFBR1 bone morphogenetic protein receptor type 2 transforming growth factor beta receptor 1
  • Signaling by BMP
  • Downregulation of TGF-beta receptor signaling
  • Downregulation of TGF-beta receptor signaling
  • TGF-beta receptor signaling activates SMADs
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)
  • SMAD2/3 Phosphorylation Motif Mutants in Cancer
  • TGFBR2 Kinase Domain Mutants in Cancer
  • TGFBR1 KD Mutants in Cancer
  • TGFBR1 LBD Mutants in Cancer
  • UCH proteinases
  • Ub-specific processing proteases
  • 4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline
  • Naphthyridine Inhibitor
  • 3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole
  • N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide
  • 2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine
  • N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine
  • Loeys-Dietz syndrome (LDS)
  • Familial thoracic aortic aneurysm and dissection (TAAD); Aortic aneurysm familial thoracic type (AAT)
BMPR2 and GDF5 bone morphogenetic protein receptor type 2 growth differentiation factor 5
  • Signaling by BMP
  • Molecules associated with elastic fibres
  • Isopropyl Alcohol
  • Brachydactyly, including: Brachydactyly type C; Angel shaped phalangoepiphyseal dysplasia (ASPED)
  • Other brachydactylies, including: Proximal symphalangism; Multiple synostosis syndrome
  • Grebe dysplasia; Acromesomelic dysplasia Hunter-Thompson type
  • Fibular hypoplasia and complex brachydactyly; DuPan syndrome
BMPR2 and TUBB4A bone morphogenetic protein receptor type 2 tubulin beta 4A class IVa
  • Signaling by BMP
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR)
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Hedgehog 'off' state
  • Cilium Assembly
  • Anchoring of the basal body to the plasma membrane
  • Intraflagellar transport
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • Epothilone D
  • Patupilone
  • CYT997
  • ZEN-012
BMPR2 and LIMK1 bone morphogenetic protein receptor type 2 LIM domain kinase 1
  • Signaling by BMP
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • EPHB-mediated forward signaling
  • Sema3A PAK dependent Axon repulsion
  • Sema3A PAK dependent Axon repulsion
  • Sema4D induced cell migration and growth-cone collapse
  • RHO GTPases Activate ROCKs
  • RHO GTPases activate PAKs
  • Dabrafenib
BMPR2 and ACTR8 bone morphogenetic protein receptor type 2 actin related protein 8
  • Signaling by BMP
  • UCH proteinases
  • DNA Damage Recognition in GG-NER
BMPR2 and NOP56 bone morphogenetic protein receptor type 2 NOP56 ribonucleoprotein
  • Signaling by BMP
  • Association of TriC/CCT with target proteins during biosynthesis
  • rRNA modification in the nucleus and cytosol
  • Major pathway of rRNA processing in the nucleolus and cytosol
  • Spinocerebellar ataxia (SCA); Machado-Joseph disease (SCA3)
BMPR2 and TRIB3 bone morphogenetic protein receptor type 2 tribbles pseudokinase 3
  • Signaling by BMP
  • PIP3 activates AKT signaling
  • Activation of AKT2
  • PPARA activates gene expression
  • Negative regulation of the PI3K/AKT network
  • CD28 dependent PI3K/Akt signaling
  • VEGFR2 mediated vascular permeability
  • Response of EIF2AK4 (GCN2) to amino acid deficiency
  • Response of EIF2AK1 (HRI) to heme deficiency
BMPR2 and PMPCA bone morphogenetic protein receptor type 2 peptidase, mitochondrial processing subunit alpha
  • Signaling by BMP
  • Mitochondrial protein import
  • Processing of SMDT1
BMPR2 and CCDC89 bone morphogenetic protein receptor type 2 coiled-coil domain containing 89
  • Signaling by BMP

Page 40 out of 266 pages